Epidemiology and outcomes of multidrug-resistant tuberculosis in Rwanda - 24/12/25
Highlights |
• | MDR-TB prevalence in Rwanda was 0.96%, with high treatment success (93.5%). |
• | GeneXpert tests achieved 92.9% sensitivity for rifampicin and isoniazid resistance. |
• | Mortality was associated with HIV co-infection and malnutrition (BMI < 18.5 kg/m 2 ). |
Abstract |
Introduction |
Multidrug-resistant tuberculosis (MDR-TB) is a significant public health challenge in Rwanda.
Methods |
This retrospective study aimed to describe the epidemiological characteristics, diagnostic approaches, and treatment outcomes of MDR-TB cases between July 1, 2019 and June 30, 2023.
Results |
Among 23,476 tuberculosis cases diagnosed in Rwanda, 227 (0.96 %) were confirmed as MDR-TB. Key findings include male predominance (80.6 %) and a mean age of 39.6 years. Pulmonary tuberculosis accounted for 96.9 % of cases, and 20.3 % of patients were co-infected with HIV. The GeneXpert molecular diagnostic test − the first-line diagnostic tool − demonstrated a sensitivity of 92.9 % for detecting resistance to rifampicin and isoniazid. The overall therapeutic success rate was 93.5 %, with a mortality rate of 5.3 % in evaluable cases (82.4 %). Risk factors for mortality included HIV co-infection and malnutrition (BMI < 18.5 kg/m 2 ).
Conclusion |
These findings underscore the importance of robust diagnostic and treatment strategies to control MDR-TB in Rwanda.
Le texte complet de cet article est disponible en PDF.Keywords : MDR-TB, Rwanda, GeneXpert, HIV co-infection, Tuberculosis treatment outcomes
Plan
Vol 56 - N° 1
Article 105200- janvier 2026 Retour au numéro
Article précédent
- Diagnostic performances of Anyplex MTB/NTM Real-time detection vs Xpert® MTB/RIF Ultra for tuberculosis among people living with human immunodeficiency virus with low CD4 count
- Alina Gaxiola-Castro, Samantha Flores-Treviño, Paola Bocanegra-Ibarias, Mariana Ramírez-Yáñez, Adrián Camacho-Ortiz
- Seasonal influenza and pneumococcal vaccination coverage among immunocompromised adults in France: A need for improvement
- Marine Cailleaux, Frédéric Balusson, Fabienne Pelé, Gaëlle Bury, Sophie Reissier, Marion Baldeyrou, Lilian Alix, Anastasia Saade, Elisabeth Polard, Pierre Tattevin
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?